Founded in 2008, we are a privately-held biotech company with two primary areas of business: Pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs.
Our focus is the metabolic space (obesity, diabetes, NASH and diabetic complications) where we specialize in in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, NGS (next generation se...
Founded in 2008, we are a privately-held biotech company with two primary areas of business: Pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs.
Our focus is the metabolic space (obesity, diabetes, NASH and diabetic complications) where we specialize in in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, NGS (next generation sequencing), bioinformatics and ex vivo assays.
We work with some of the most interesting and loyal partners and customers from across the world within big pharma, biotech and academia.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.